Skip to Main Content

Author Details

David M Parham
Keck School of Medicine, University of Southern California
1977
340
66
PMIDPaper TitleJournal TitlePublished Year
37196343The Pathologic Diagnosis of Pediatric Soft Tissue Tumors in the Era of Molecular Medicine: The Sarcoma Pediatric Pathology Research Interest Group Perspective.Arch Pathol Lab Med2024
37196343The Pathologic Diagnosis of Pediatric Soft Tissue Tumors in the Era of Molecular Medicine: The Sarcoma Pediatric Pathology Research Interest Group Perspective.Arch Pathol Lab Med2024
36566574Lymph node metastases in paediatric and young adult patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): Findings from Children's Oncology Group (COG) study ARST0332.Eur J Cancer2023
37265193FGFR1 gene fusions in a subset of pediatric mesenchymal tumors: Expanding the genetic spectrum of tumors sharing histologic overlap with infantile fibrosarcoma and "NTRK-rearranged" spindle cell neoplasms.Genes Chromosomes Cancer2023
36566574Lymph node metastases in paediatric and young adult patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): Findings from Children's Oncology Group (COG) study ARST0332.Eur J Cancer2023
37194615TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report.Pediatr Blood Cancer2023
37265193FGFR1 gene fusions in a subset of pediatric mesenchymal tumors: Expanding the genetic spectrum of tumors sharing histologic overlap with infantile fibrosarcoma and "NTRK-rearranged" spindle cell neoplasms.Genes Chromosomes Cancer2023
37194615TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report.Pediatr Blood Cancer2023
35051261An Integrative Morphologic and Molecular Approach for Diagnosis and Subclassification of Rhabdomyosarcoma.Arch Pathol Lab Med2022
35626119Pediatric Sarcomas: The Next Generation of Molecular Studies.Cancers (Basel)2022
35051261An Integrative Morphologic and Molecular Approach for Diagnosis and Subclassification of Rhabdomyosarcoma.Arch Pathol Lab Med2022
35626119Pediatric Sarcomas: The Next Generation of Molecular Studies.Cancers (Basel)2022
32668033The Relevance of and Surgical Approach to the Suprahyoid Region in Thyroglossal Duct Surgery.Laryngoscope2021
33470921Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome.Pediatr Dev Pathol2021
34107813Rhabdomyosarcoma: How Advanced Molecular Methods Are Shaping the Diagnostic and Therapeutic Paradigm.Pediatr Dev Pathol2021
33439112Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis⿿⿦⿿But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.Pediatr Dev Pathol2021
33245207Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups.Pediatr Blood Cancer2021
33302115The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group.Eur J Cancer2021
33031223Clinicopathologic Characteristics of Late Acute Antibody-mediated Rejection in Pediatric Liver Transplantation.Transplantation2021
32949727Histopathologic features of alveolar capillary dysplasia with misalignment of pulmonary veins with atypical clinical presentation.Cardiovasc Pathol2021
32668033The Relevance of and Surgical Approach to the Suprahyoid Region in Thyroglossal Duct Surgery.Laryngoscope2021
33433254A History of Board Certification in Pediatric Pathology on Its 30th Anniversary.Pediatr Dev Pathol2021
34107813Rhabdomyosarcoma: How Advanced Molecular Methods Are Shaping the Diagnostic and Therapeutic Paradigm.Pediatr Dev Pathol2021
33433254A History of Board Certification in Pediatric Pathology on Its 30th Anniversary.Pediatr Dev Pathol2021
33031223Clinicopathologic Characteristics of Late Acute Antibody-mediated Rejection in Pediatric Liver Transplantation.Transplantation2021
33245207Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups.Pediatr Blood Cancer2021
33302115The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group.Eur J Cancer2021
33470921Epithelioid Sarcoma Arising in a Long-Term Survivor of an Atypical Teratoid/Rhabdoid Tumor in a Patient With Rhabdoid Tumor Predisposition Syndrome.Pediatr Dev Pathol2021
33439112Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis⿿⿦⿿But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.Pediatr Dev Pathol2021
32949727Histopathologic features of alveolar capillary dysplasia with misalignment of pulmonary veins with atypical clinical presentation.Cardiovasc Pathol2021
31537896Expanding the spectrum of dicer1-associated sarcomas.Mod Pathol2020
31786124A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.Lancet Oncol2020
32703985Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children's Oncology Group.Sci Rep2020
31537896Expanding the spectrum of dicer1-associated sarcomas.Mod Pathol2020
31215292Infantile Epithelioid Sarcoma with Genomic Segmental Amplification of <i>BIRC3/YAP1</i> as Double Minutes Plus Trisomy 2: A Case Report.Fetal Pediatr Pathol2020
31786124A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.Lancet Oncol2020
32703985Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children's Oncology Group.Sci Rep2020
31215292Infantile Epithelioid Sarcoma with Genomic Segmental Amplification of <i>BIRC3/YAP1</i> as Double Minutes Plus Trisomy 2: A Case Report.Fetal Pediatr Pathol2020
29516773On the First Usage of the Term "Rhabdomyosarcoma".Pediatr Dev Pathol2019
30351457The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.Cancer2019
30585824Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors.Am J Surg Pathol2019
30194760The incidence of microscopic thyroglossal duct tissue superior to the hyoid bone.Laryngoscope2019
30468401English Translation of M. Bérard: Tumeur Embryonnaire Du Muscle Strié. [Embryonal Tumor of Striated Muscle]. Lyon Med 1894; 77: 52.Fetal Pediatr Pathol2019
29516773On the First Usage of the Term "Rhabdomyosarcoma".Pediatr Dev Pathol2019
30929036Magnetic resonance and computed tomography imaging features of epithelioid sarcoma in children and young adults with pathological and clinical correlation: a report from Children's Oncology Group study ARST0332.Pediatr Radiol2019
31067356Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group.Cancer2019
30954717Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.Eur J Cancer2019
30194760The incidence of microscopic thyroglossal duct tissue superior to the hyoid bone.Laryngoscope2019
30954717Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.Eur J Cancer2019
31067356Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group.Cancer2019
  • 1 - 50 of 680

Recommended Authors

Children's Hospital of Los Angeles
Career Start Year 2008
Number of shared co-authors 5
12235University of Miami Miller School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 1
Department of Pathology and Laboratory Medicine Aga Khan University Hospital Karachi
Career Start Year 2001
Number of shared co-authors 1
University of California los angeles
Career Start Year 2001
Number of shared co-authors 4
University of Virginia Department of Pathology
Career Start Year 2001
Number of shared co-authors 17
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 5
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 4
Institut Curie
Career Start Year 1999
Number of shared co-authors 0
Schulich School of Medicine & Dentistry, Western University
Career Start Year 1998
Number of shared co-authors 2
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 1997
Number of shared co-authors 5
Memorial Sloan Kettering Cancer Center
Career Start Year 1997
Number of shared co-authors 15
Oregon Health & Science University
Career Start Year 1996
Number of shared co-authors 16
University Hospital of Tours
Career Start Year 1996
Number of shared co-authors 0
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 10
University College London, UCL Cancer Institute
Career Start Year 1994
Number of shared co-authors 10
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 5
Washington University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Nancy University Hospital
Career Start Year 1993
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 3
Hadassah Hebrew University Hospital
Career Start Year 1992
Number of shared co-authors 1
University Medical Center Freiburg, University of Freiburg
Career Start Year 1990
Number of shared co-authors 20
The Johns Hopkins Hospital
Career Start Year 1987
Number of shared co-authors 5
Flinders University Library, Flinders University
Career Start Year 1985
Number of shared co-authors 11
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 1
Hyogo Cancer Center
Career Start Year 1984
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1978
Number of shared co-authors 5
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 10
Oita University
Career Start Year 1965
Number of shared co-authors 0

Collaborators

Co-authored papers 30
St Jude Children's Research Hospital
Co-authored papers 23
The University of Texas Health Science Center at San Antonio
Co-authored papers 18
Center for Cancer Research
Co-authored papers 14
Center for Epigenetics, Van Andel Research Institute
Co-authored papers 8
Stanford University School of Medicine
Co-authored papers 8
Baylor College of Medicine
Co-authored papers 7
University of Oklahoma Health Sciences Center
Co-authored papers 6
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
and Clinical Center, Central Arkansas Veterans Healthcare System
Co-authored papers 3
Co-authored papers 3
University of British Columbia
Co-authored papers 3
Co-authored papers 3
Co-authored papers 2
Children's Cancer Therapy Development Institute
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 2
Children's Hospital Los Angeles
Co-authored papers 2
British Columbia Cancer Research Centre
Co-authored papers 2
Co-authored papers 2
Boston Children's Hospital
Co-authored papers 2
Co-authored papers 2
Texas Children's Cancer Center, Baylor College of Medicine
Co-authored papers 2
Co-authored papers 2
Children's Hospital Los Angeles
Co-authored papers 2
National Cancer Institute
Co-authored papers 2